Literature DB >> 3686025

Thrombospondin in milk, other breast secretions, and breast tissue.

J Dawes1, P Clezardin, D A Pratt.   

Abstract

Colostrum and milk contained high concentrations of thrombospondin, although the concentration relative to total protein content decreased as lactation was established. Thrombospondin occurred in the aqueous phase of milk rather than as a component of the milk fat globule membrane. It could be purified from colostrum using established procedures after removal of lipid from the starting material. The intact protein had a molecular weight of 450 kd, but the product contained small peptides, perhaps as a result of proteolytic activity in the colostrum. Thrombospondin from goat colostrum displayed a different proteolytic fragmentation pattern from thrombospondins isolated from three human sources, but this could be a species- rather than tissue-specific difference. Breast cancer cytosols contained significantly more thrombospondin than cytosols from normal tissue or benign dysplasias. Thrombospondin levels in a variety of breast secretions all fell within the range found in colostrum and milk, as did the fluids from Na+ (group II) breast cysts. K+ (group I) cysts, however, contained fluids with low thrombospondin concentrations, eliminating apocrine cells as the source of thrombospondin in the breast.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3686025     DOI: 10.1055/s-2007-1003514

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  7 in total

Review 1.  Thrombospondin as a mediator of cancer cell adhesion in metastasis.

Authors:  D A Walz
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

2.  TXR1 and TSP1 expression varies by the molecular subtypes of breast cancer patients who received previous docetaxel-based first-line chemotherapy.

Authors:  Huiming Zhang; Xiang Qu; Xuemei Ma; Tingting Wang; Yao Yang; Zhicheng Ge; Zhongtao Zhang; Zhigang Bai; Yinguang Gao; Zhu Yuan; Zihan Wang
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-12

3.  Immunohistochemical study of thrombospondin and its receptors alpha root of beta 3 and CD36 in normal thyroid and in thyroid tumours.

Authors:  M Patey; B Delemer; G Bellon; L Martiny; M Pluot; B Haye
Journal:  J Clin Pathol       Date:  1999-12       Impact factor: 3.411

4.  Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. An immunohistochemical study.

Authors:  S Y Wong; A T Purdie; P Han
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

5.  Distribution of thrombospondin and integrin alpha V in DCIS, invasive ductal and lobular human breast carcinomas. Analysis by electron microscopy.

Authors:  C M Serre; P Clezardin; L Frappart; G Boivin; P D Delmas
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium.

Authors:  M L Iruela-Arispe; P Porter; P Bornstein; E H Sage
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

7.  Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva.

Authors:  R Crombie; R L Silverstein; C MacLow; S F Pearce; R L Nachman; J Laurence
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.